Case Report
Accepted on 23 Sep 2025
Diagnosis and Treatment of Giant thoracodorsal Liposarcoma: A Case Report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1570796
Type at least 3 characters
1,493 articles
Original Research
Accepted on 23 Sep 2025
The Role of Immune-and Lipid Metabolism-Related Genes in Macrophage Polarization and Prognosis of Glioblastoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1660754
Original Research
Accepted on 23 Sep 2025
Ferroptosis's Master Switch GPX4 Emerges as Universal Biomarker for Precision Immunotherapy: A Pan-cancer Study with in vitro experiments validation
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1643235
Original Research
Accepted on 22 Sep 2025
Treatment experience in managing severe immune-mediated hepatotoxicity induced by immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1657332
- 993 views
Original Research
Accepted on 22 Sep 2025
Dextran sulfate inhibits the invasion, migration, and programmed death ligand 1 expression in human gastric cancer cells by affecting the M2 tumor-associated macrophages polarization
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1689053
- 137 views
Systematic Review
Accepted on 22 Sep 2025
The effect of Tislelizumab on Complete and Pathological Complete Response in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1657282
- 187 views
Original Research
Accepted on 22 Sep 2025
Predictive Value of Early Changes in Serum CEA, CYFRA21-1, and SCC-Ag for Efficacy and Prognosis in Advanced Lung Squamous Cell Carcinoma Treated with First-Line Immunotherapy Combined with Chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1561602
- 129 views
Original Research
Published on 22 Sep 2025
Efficacy and safety of immune checkpoint inhibitor rechallenge therapy in the treatment of advanced acquired immune-resistant non-small cell lung cancer: a retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1621860
- 453 views
Review
Published on 22 Sep 2025
Advances in the mechanism and therapeutic potential of neutrophil extracellular traps in cancer promotion
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1593510
- 497 views
Original Research
Accepted on 19 Sep 2025
Personalized medicine in Triple-Negative Breast Cancer: Combining Neoantigen Vaccination and Genomic Profiling in a patient Undergoing Neoadjuvant Chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1623402
- 544 views
Case Report
Published on 18 Sep 2025
Case Report: Safety and efficacy assessment of teclistamab in relapsed/refractory amyloidosis: a case study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1664171
- 669 views
Brief Research Report
Accepted on 17 Sep 2025
Evaluating the Impact of Immune Checkpoint Inhibitors on Liver Steatosis and Function: A Retrospective Cohort Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1683982
- 542 views
Case Report
Accepted on 16 Sep 2025
Failed response to anti-PD-1 immunotherapy in a colon cancer patient with high microsatellite instability: A case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1636122
- 716 views
Mini Review
Accepted on 16 Sep 2025
Microbiome-Mediated Regulation of Chemoradiotherapy Response
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1659467
- 432 views
Original Research
Published on 16 Sep 2025
Machine learning-based analysis identifies glucose metabolism-related genes ADPGK as potential diagnostic biomarkers for clear cell renal cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1559887
- 646 views
Original Research
Published on 12 Sep 2025
Application of immunotherapy in advanced non-small cell lung cancer with hypertension: a multicenter retrospective analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1621363
- 1,997 views